Left ventricle structural remodelling in the prediabetic Goto-Kakizaki rat

Experimental Physiology

Volumn 96, Issue 9, 2011, Pages 875-888

  D'Souza, Alicia ^a   Howarth, Frank C ^b   Yanni, Joseph ^c   Dobryznski, Halina ^c   Boyett, Mark R ^c   Adeghate, Ernest ^b   Bidasee, Keshore R ^d   Singh, Jaipaul ^a  

^a UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; BRAIN NATRIURETIC PEPTIDE; COLLAGEN TYPE 1; CONNECTIVE TISSUE GROWTH FACTOR; FIBRONECTIN; GELATINASE A; GELATINASE B; GLUCOSE; PROTEIN KINASE B; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART SIZE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMPAIRED GLUCOSE TOLERANCE; LEFT VENTRICLE STRUCTURAL REMODELLING; MALE; NONHUMAN; PHENOTYPE; QUANTITATIVE GENETICS; RAT; SIGNAL TRANSDUCTION; STUDENT T TEST;

EID: 80051930406     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2011.058271     Document Type: Article

References (49)

1. Adeghate E, Howarth FC, Rashed H, Saeed T & Gbewonyo A (2006). The effect of a fat-enriched diet on the pattern of distribution of pancreatic islet cells in the C57BL/6J mice. Ann N Y Acad Sci 1084, 361-370.
2. Bergman M (2010). Inadequacies of absolute threshold levels for diagnosing prediabetes. Diabetes Metab Res Rev 26, 3-6.
3. Boudina S & Abel ED (2010). Diabetic cardiomyopathy, causes and effects. Rev Endocr Metab Disord 11, 31-39.
4. Chadwick TV, Coker ML, Zellner JL, Handy JR, Crumbley AJ 3rd & Spinale FG (1998). Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy. Circulation 97, 1708-1715.
5. Clément S, Chaponnier C & Gabbiani G (1999). A Subpopulation of cardiomyocytes expressing α-skeletal actin is identified by a specific polyclonal antibody. Circ Res 85, e51-e58.
6. WHO (2006). Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. Available from (accessed 10 January 2010).
7. Diabetes UK (2009). Prediabetes; preventing the type 2 diabetes epidemic. Available from: (accessed 10 January 2010).
8. Fedak P, Verma S, Weisel RD & Li RK (2005). Cardiac remodelling and failure: from molecules to man (part 1). Cardiovasc Pathol 14, 1-11.
9. Fredersdorf S, Thumann C, Ulucan C, Griese DP, Luchner A, Riegger GA, Kromer EP & Weil J (2004). Myocardial hypertrophy and enhanced left ventricular contractility in Zucker diabetic fatty rats. Cardiovasc Pathol 13, 11-19.
10. Fujii M, Wada A, Tsutamoto T, Ohnishi M, Isono T & Kinoshita M (2002). Bradykinin improves left ventricular diastolic function under long-term angiotensin-converting enzyme inhibition in heart failure. Hypertension 39, 952-957.
11. Fujita M, Asanuma H, Kim J, Liao Y, Hirata A, Tsukamoto O, Minamino T, Hori M, Goto M, Node K & Kitakaze M (2007). Impaired glucose tolerance: a possible contributor to left ventricular hypertrophy and diastolic dysfunction. Int J Cardiol 118, 76-80.
12. Goraksha-Hicks P & Rathmell JC (2009). TGF-β: a new role for an old AktTOR. Dev Cell 17, 6-8.
13. Goto Y, Kakizaki M & Masaki N(1975). Spontaneous diabetes produced by selective breeding of normal Wistar rats. Proc Jpn Acad 51, 80-85.
14. Gupte S, Labinskyy N, Gupte, Csiszar A, Ungvari Z & Edwards JG (2010). Role of NAD(P)H oxidase in superoxide generation and endothelial dysfunction in Goto-Kakizaki (GK) rats as a model of non-obese NIDDM. PLoS One 25, e11800.
15. He JG, Chen YL, Chen BL, Huang YY, Yao FJ, Chen SL & Dong YG (2010). B-type natriuretic peptide attenuates cardiac hypertrophy via the transforming growth factor-β1/smad7 pathway in vivo and in vitro. Clin Exp Pharmacol Physiol 37, 283-289.
16. Howarth FC, Shafiullah M & Qureshi MA (2007). Chronic effects of type 2 diabetes mellitus on cardiac muscle contraction in the Goto-Kakizaki rat. Exp Physiol 92, 1029-1036.
17. Kamiński KA, Szepietowska B, Bonda T, Kozuch M, Mencel J, Malkowski A, Sobolewski K, Kovalchuk O, Chyczewski L, Szelachowska M, Górska M, Musial WJ & Winnicka MM (2009). CCN2 protein is an announcing marker for cardiac remodeling following STZ-induced moderate hyperglycemia in mice. Pharmacol Rep 61, 496-503.
18. Kelly DJ, Zhang Y, Connelly K, Cox AJ, Martin J, Krum H & Gilbert RE (2007). Tranilast attenuates diastolic dysfunction and structural injury in experimental diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 293, H2860-H2869.
19. Langenickel T, Pagel I, Höhnel K, Dietz R & Willenbrock R (2000). Differential regulation of cardiac ANP and BNP mRNA in different stages of experimental heart failure. Am J Physiol Heart Circ Physiol 278, H1500-H1506.
20. Leask A (2010). Potential therapeutic targets for cardiac fibrosis: TGFβ, angiotensin, endothelin, CCN2 and PGDF, partners in fibroblast activation. Circ Res 106, 1675-1680.
21. Legato MJ, Mulieri LA & Alpert NR (1984). The ultrastructure of myocardial hypertrophy: why does the compensated heart fail? Eur Heart J 5(Suppl F), 251-259.
22. Li YY, Feng YQ, Kadokami T, McTiernan CF, Draviam R, Watkins SC & Feldman AM (2000). Myocardial extracellular matrix remodelling in transgenic mice overexpressing tumour necrosis factor α can be modulated by anti-tumour necrosis factor α therapy. Proc Natl Acad Sci USA 97, 12746-12751.
23. 1. Mol Genet Metab 71, 418-435.
24. Lukowicz TV, Fischer M, Hense HW, Döring A, Stritzke J, Riegger G, Schunkert H & Luchner A; MONICA Investigators (2005). BNP as a marker of diastolic dysfunction in the general population: importance of left ventricular hypertrophy. Eur J Heart Fail 7, 525-531.
25. Manning BD & Cantley LC (2007). AKT/PKB signaling: navigating downstream. Cell 129, 1261-1274.
26. Matsumoto-Ida M, Takimoto Y, Aoyama T, Akao M, Takeda T & Kita T (2006). Activation of TGF-β1-TAK1-p38 MAPK pathway in spared cardiomyocytes is involved in left ventricular remodeling after myocardial infarction in rats. Am J Physiol Heart Circ Physiol 290, H709-H715.
27. Mizushige K, Yao L & Noma T (2000). Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model. 101, 899-907.
28. Munger MA, Johnson M, Amber IJ, Callahan KS & Gilbert EM (1996). Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 77, 723-727.
29. Nielsen C & Lange T (2005). Blood glucose and heart failure in nondiabetic patients. Diabetes Care 28, 607-611.
30. Parker TG, Packer SE & Schneider MD (1990). Peptide growth factors can provoke 'fetal' contractile protein gene expression in rat cardiac myocytes. J Clin Invest 85, 507-514.
31. Poornima IG, Parikh P & Shannon RP (2006). Diabetic cardiomyopathy: the search for a unifying hypothesis. Circ Res 98, 596-605.
32. Portha B, Serradas P, Bailbé D, Suzuki K, Goto Y & Giroix MH (1991). β-Cell insensitivity to glucose in the GK rat, a spontaneous non-obese model for type II diabetes. Diabetes 40, 486-491.
33. Ramos-Mondragón R, Galindo CA & Avila G (2008). Role of TGF-β on cardiac structural and electrical remodelling. Vasc Health Risk Manag 4, 1289-1300.
34. Schainberg A, Riberio-Oliveira A Jr & Riberio JM (2010). Is there a link between glucose levels and heart failure? An update. Arq Bras Endocrinol Metab 54, 488-497.
35. Schultz J, Witt SA, Glascock BJ, Nieman ML, Reiser PJ, Nix SL, Kimball TR & Doetschman T (2002). TGF-β1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II. J Clin Invest 109, 787-796.
36. Seeland U, Kouchi I, Zolk O, Itter G, Linz W & Böhm M (2002). Effect of ramipril and furosemide treatment on interstitial remodeling in post-infarction heart failure rat hearts. J Mol Cell Cardiol 34, 151-163.
37. Seeland U, Selejan S & Engelhardt S (2007). Interstitial remodeling in β1-adrenergic receptor transgenic mice. Basic Res Cardiol 102, 183-193.
38. Sovari AS & Dudley SC (2010). Using serum transforming growth factor-β to predict myocardial fibrosis. Circ Res 106, e3.
39. Stilli D, Bocchi L, Berni R, Zaniboni M, Cacciani F, Chaponnier C, Musso E, Gabbiani G & Clément S (2006). Correlation of α-skeletal actin expression, ventricular fibrosis and heart function with the degree of pressure overload cardiac hypertrophy in rats. Exp Physiol 91, 571-580.
40. Taegtmeyer H, Sen S & Vela D (2010). Return to the fetal gene program. Ann NY Acad Sci 1188, 191-198.
41. Van Linthout S, Seeland U, Riad A, Eckhardt O, Hohl M, Dhayat N, Richter U, Fischer JW, Böhm M, Pauschinger M, Schultheiss HP & Tschöpe C (2008). Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy. Basic Res Cardiol 103, 319-327.
42. Verrecchia F & Mauvel A (2007). Transforming growth factor-β and fibrosis. World J Gastroenterol 13, 3065-3062.
43. Wang X, Beugnet A, Murakami M, Yamanaka S & Proud CG (2005). Distinct signalling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins. Mol Cell Biol 25, 2558-2752.
44. Wu L & Derynck R (2009). Essential role of TGF-β signalling in glucose-induced cell hypertrophy. Dev Cell 17, 35-48.
45. Yagi K, Shokei K, Wanibuchi H, Yamashita T, Yamamura Y & Iwao H (1997). Characteristics of diabetes, blood pressure and cardiac and renal complications in Otsuka Long-Evans Tokushima fatty rats. Hypertension 29, 728-735
46. Yanni J, Tellez JO, Sutyagin PV, Boyett MR & Dobrzynski H (2010). Structural remodelling of the sinoatrial node in obese old rats. J Mol Cell Cardiol 48, 653-62.
47. Yasushi A, Tomoda M, Murata Y, Inui H, Sugiura M & Nakano Y (2007). Antidiabetic effect of long-term supplementation with Siraitia grosvenori on the spontaneously diabetic Goto-Kakizaki rat. Br J Nutr 97, 770-775.
48. Zheng H, Mayhan WG, Bidasee KR & Patel KP (2005). Blunted nitric oxide-mediated inhibition of sympathetic nerve activity within the paraventricular nucleus in diabetic rats. Am J Physiol Regul Integr Comp Physiol 290, R992-R1002.
49. Ziyadeh FN (2004). Mediators of diabetic renal disease: the case for TGF-β as the major mediator. J Am Soc Nephrol 15(Suppl 1), S55-S57.